To functionally explore whether H3K9 demethylation selectively affects leukemia cells, we treated AML cells and cKit+ BM cells with chaetocin, a small-molecule inhibitor of H3K9 methylation34–36 (Supplementary Fig. 8c). Here, KIT is linked to leukemia.